Cardiovascular pharmacotherapy update for the intensive care unit

Critical Care Nursing Quarterly

Volumn 30, Issue 1, 2007, Pages 44-57

  Coons, James C ^a   Seidl, Edward ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Inotrope; Titration; Vasodilator; Vasopressor

Indexed keywords

ADRENALIN; AMRINONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; MILRINONE; NESIRITIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE III INHIBITOR; PLACEBO; VASODILATOR AGENT; VASOPRESSIN;

ABDOMINAL CRAMP; ACUTE DECOMPENSATED HEART FAILURE; ADD ON THERAPY; ANAPHYLAXIS; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEART AFTERLOAD; HEART ARREST; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PRELOAD; HEART PROARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXEMIA; INTENSIVE CARE NURSING; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LOW DRUG DOSE; LUNG EDEMA; LUNG VASCULAR RESISTANCE; MEDICAL SOCIETY; META ANALYSIS; NAUSEA; REVIEW; SEPTIC SHOCK; SIDE EFFECT; SUDDEN DEATH; SYSTEMATIC REVIEW; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; VASODILATATION; VOMITING;

EID: 33846008753     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200701000-00006     Document Type: Review

References (39)

1. Adams KF, Lindenfeld J, Arnold JMO, et al. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Cardiac Fail. 2006;12:10-38.
2. The VMAC Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure. JAMA. 2002;287:1531-1540.
3. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246-253.
4. Scios, Inc. Natrecor (Nesiritide) Package Insert. Fremont, Calf: Scios Inc; 2005.
5. Burger A, Dennish G, Horton D, et al. Nesiritide therapy for decompensated CHF is not proarrhythmic. J Am Coll Cardiol. 2000;35:172.
6. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004;110:1620-1625.
7. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487-1491.
8. Sackner-Bernstein JD, Kowalski M, Fox M, et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure. JAMA. 2005;293:1900-1905.
9. Scios, Inc. Data on file. 2005. Available at: http:// www.NATRECOR.com. Accessed September 28, 2006.
10. Marino PL. The ICU Book. 2nd ed. Baltimore, Md: Williams & Wilkins; 1998.
11. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care; part 7.4: monitoring and medications. Circulation. 2005;112(suppl I):IV-78-IV-83.
12. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science; part 6: advanced cardiovascular life support: section 6: pharmacology II: agents to optimize cardiac output and blood pressure. Circulation. 2000;102(8, suppl):I-129-I-135.
13. Friederich JA, Butterworth JF. Sodium nitroprusside: twenty years and counting. Anesth Analg. 1995;81:152-162.
14. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003;348(18):1756-1763.
15. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med. 1999;131:47-59.
16. Aranda JM Jr, Schofield RS, Pauly DF, et al. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J. 2003;145:324-329.
17. Yamani MH, Haji SA, Starling RC, et al. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact. Am Heart J. 2001;142(6):998-1002.
18. Baruch L, Patacsil P, Hameed A, et al. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J. 2000;141:e6.
19. The OPTIME-CHF Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure. JAMA. 2002;287:1541-1547.
20. Higginbotham MB, Russel SD, Mehra MR, et al. Bridging patients to cardiac transplantation. Congest Heart Fail. 2000;6:238-242.
21. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30(4):536-535.
22. Hollenerg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32:1928-1948.
23. Beale RJ, Hollenberg SM, Vincent JL, et al. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004(suppl):S455-S465.
24. Power DA. Duggan J. Brady HR. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Clin Exp Pharmacol Physiol. 1999;26(suppl):S23- S28.
25. ANZICS Clinical Trials Group. Low dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Lancet. 2000;356:2139-2143.
26. Kellum JA, Decker JM. Use of Dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001;29:1526-1530.
27. Aragalious M, Motta P, Khandwala F, et al. "Renal dose" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med. 2005;33:1327-1332.
28. Leier CV, Binkley PF. Parenteral inotropic support for advanced congestive heart failure. Prog Cardiovasc Dis. 1998;41:207-224.
29. Martin C, Viviand X, Leone M, et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000;28(8):2758-2765.
30. Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med. 2003;31:1752-1758.
31. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-1125.
32. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25(8):1279-1282.
33. Lin I, Ma H, Lin AC, et al. Low plasma vasopressin/ norepinephrine ratio predict septic shock. Am J Emerg Med. 2005;23:718-724.
34. Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002;30:497-500.
35. Holmes CL, Wallety KR, Chittock DR, et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: case series. Intensive Care Med. 2001;27:1416-1421.
36. Dunser MW, Mayer AJ, Ulmer H, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001;93:7-13.
37. Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487-493.
38. Malay MB, Ashton RC, Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47(4):699-705.
39. Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96(3):576-582.